Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats

<p>Scatter plot and score scatter 3D plots following PCA analysis. Red represents DEPs of the MCAO model group and blue represents DEPs of the NMT group.</p>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats 